| |
| |
|
| Insider
Information: |
Stein Robert Benjamin |
| Relationship: |
President, Regenerativ... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
578,789 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,332,447 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
578,789 |
|
|
| Total
Value |
$2,332,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
10
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.3
|
| Percentage
Gain/Loss : |
0.0%
|
 577.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antigenics Inc |
AGEN |
President R&D |
2016-04-26 |
20,986 |
2016-04-26 |
0 |
Premium* |
|
|
Protagenic Therapeutics Ord Shs |
PTIX |
Director |
2016-06-17 |
240,000 |
2016-06-17 |
0 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
President, Regenerativ... |
2023-05-16 |
317,803 |
2020-08-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2023-05-16 |
4 |
S |
$5.95 |
$61,627 |
D/D |
(10,365) |
317,803 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2023-05-15 |
4 |
S |
$6.15 |
$22,170 |
D/D |
(3,607) |
328,168 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2023-05-10 |
4 |
S |
$5.93 |
$34,780 |
D/D |
(5,869) |
331,775 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2023-05-04 |
4 |
S |
$5.34 |
$276,470 |
D/D |
(51,756) |
337,644 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2023-04-25 |
4 |
S |
$3.74 |
$22,415 |
D/D |
(5,987) |
389,400 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2023-04-11 |
4 |
S |
$3.31 |
$19,847 |
D/D |
(5,996) |
395,387 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2023-03-07 |
4 |
S |
$4.24 |
$52,442 |
D/D |
(12,355) |
266,318 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2022-09-13 |
4 |
S |
$3.46 |
$28,785 |
D/D |
(8,329) |
278,673 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2022-09-12 |
4 |
S |
$3.44 |
$65,284 |
D/D |
(19,000) |
287,002 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2022-08-12 |
4 |
S |
$4.04 |
$34,344 |
D/D |
(8,503) |
306,002 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2022-08-04 |
4 |
S |
$3.62 |
$70,590 |
D/D |
(19,500) |
314,505 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2022-06-28 |
4 |
S |
$3.47 |
$50,662 |
D/D |
(14,600) |
334,005 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
President, Regenerative Med. |
• – – |
2022-04-08 |
4 |
A |
$4.62 |
$824,998 |
D/D |
178,571 |
348,605 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
EVP, Research and Development |
• – – |
2022-03-08 |
4 |
S |
$4.86 |
$56,714 |
D/D |
(11,672) |
170,034 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
EVP, Research and Development |
• – – |
2021-08-16 |
4 |
S |
$11.85 |
$110,968 |
D/D |
(9,362) |
181,706 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
EVP, Research and Development |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
109,235 |
191,068 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
EVP, Research and Development |
• – – |
2020-08-10 |
4 |
A |
$6.11 |
$500,000 |
D/D |
81,833 |
81,833 |
0 |
- |
|
| AGEN |
Antigenics Inc |
President R&D |
• – – |
2016-04-26 |
4/A |
|
$4.15 |
$51,414 |
D/D |
12,389 |
20,986 |
0 |
- |
|
| AGEN |
Antigenics Inc |
President R&D |
• – – |
2016-04-26 |
4/A |
A |
$4.15 |
$138,506 |
D/D |
33,375 |
33,375 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Scientific Officer |
• – – |
2016-04-26 |
4 |
D |
$4.15 |
$50,900 |
D/D |
(12,265) |
20,776 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Scientific Officer |
• – – |
2016-04-26 |
4 |
A |
$4.15 |
$137,120 |
D/D |
33,041 |
33,041 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
